CompletedPhase 2NCT00708084

Randomized Phase II Trial on Safety and Neutralizing Activity of CL184 and Rabies Vaccine Versus Human Rabies Immune Globulin (HRIG) and Rabies Vaccine in Children and Adolescents

Studying Rabies

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Crucell Holland BV
Principal Investigator
Beatriz P. Quiambao, MD
Research Institute for Tropical Medicine, Alabang, Muntinlupa, Metro Manila, Philippines
Intervention
CL184(biological)
Enrollment
48 target
Eligibility
5-17 years · All sexes
Timeline
2008 – 2008

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00708084 on ClinicalTrials.gov

Other trials for Rabies

Additional recruiting or active studies for the same condition.

See all trials for Rabies →

← Back to all trials